Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(17):1172-1173; doi:10.1093/jnci/djj365
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bondy, M. L.
Right arrow Articles by Newman, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bondy, M. L.
Right arrow Articles by Newman, L. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

EDITORIAL

Assessing Breast Cancer Risk: Evolution of the Gail Model

Melissa L. Bondy, Lisa A. Newman

Affiliations of authors: Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX (MLB); Breast Care Center, Department of Surgery, Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (LAN)

Correspondence to: Melissa L. Bondy, PhD, Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439 (e-mail: mbondy@mdanderson.org) or Lisa A. Newman, MD, MPH, Breast Care Center, Department of Surgery, Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (e-mail: lanewman@med.umich.edu).

The first 10% of the full text of this article appears below.

This issue of the Journal contains two articles refining and advancing the breast cancer risk assessment model known as the Gail Model (1). This model has been shown to be well calibrated with respect to predicting the number of cancers likely to develop within cohorts of white American women with specific risk factors (2–4). As needs of the chemoprevention trials (for determining eligibility) and clinicians (in counseling patients) have grown, the Gail Model has been modified to account for history of atypia and race or ethnicity, but until now it has included only nonmodifiable risk factors (i.e., age, reproductive history, and biopsy history). It is readily available to practitioners as a user-friendly program (http://bcra.nci.nih.gov/brc/start.htm. . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
F. M. Hall and K. E. Martin, MD
Mammographic Density Categories
Radiology, October 1, 2007; 245(1): 300 - 302.
[Full Text] [PDF]

Home page
 JWatch Women's HealthHome page
Breast Density: An Important Predictor of Breast Cancer?
Journal Watch Women's Health, October 19, 2006; 2006(1019): 1 - 1.
[Full Text]

Home page
 JWatch GeneralHome page
Mammographic Breast Density in the Prediction of Breast Cancer Risk
Journal Watch (General), September 26, 2006; 2006(926): 3 - 3.
[Full Text]